Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
dasminapant (APG-1387)
i
Other names:
APG-1387, APG 1387, SM-1387, APG1387, SM1387, SM 1387
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Ascentage Pharma
Drug class:
IAP inhibitor
Related drugs:
‹
IGM-9427 (5)
AZD5582 (1)
BI 891065 (0)
GEM 640 (0)
LCL161 (0)
IGM-9427 (5)
AZD5582 (1)
BI 891065 (0)
GEM 640 (0)
LCL161 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 negative
HER2 Negative Breast Cancer
HER-2 negative
HER2 Negative Breast Cancer
APG-1387
Sensitive: C3 – Early Trials
APG-1387
Sensitive
:
C3
APG-1387
Sensitive: C3 – Early Trials
APG-1387
Sensitive
:
C3
BRCA1 mutation
Pancreatic Cancer
BRCA1 mutation
Pancreatic Cancer
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
BRCA2 mutation
Pancreatic Cancer
BRCA2 mutation
Pancreatic Cancer
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
KRAS mutation
Pancreatic Cancer
KRAS mutation
Pancreatic Cancer
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
olaparib + APG-1387
Sensitive: D – Preclinical
olaparib + APG-1387
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.